glp-1 agonist weight loss mechanism of action of agonists GLP1 Receptor Agonists—Effects beyond Obesity
Description
In the 2022 SURMOUNT-1 study published in NEJM, three doses of tirzepatide were compared with placebo (1:1:1:1) to determine effects on percent weight change over the course of 72 weeks
Exendin-4 induces cytotoxic autophagy in two ovarian cancer cell lines through inhibition of Mtorc1 mediated by activation of AMPK and suppression of akt
Primary care appointments are short
Dealing with limited overlap in estimation of average treatment effects
Orlistat causes gastrointestinal effects (oily stools, flatulence) but only when dietary fat is consumed
